1.01
price down icon3.35%   -0.035
 
loading

Valion Bio Inc Aktie (VBIO) Neueste Nachrichten

pulisher
May 05, 2026

Valion Bio Appoints Melinda Lackey as General Counsel - The Globe and Mail

May 05, 2026
pulisher
May 05, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 05, 2026
pulisher
May 05, 2026

Valion Bio Names Melinda Lackey General Counsel as It Advances Immunotherapy Pipeline and Regulatory Strategy - citybiz

May 05, 2026
pulisher
May 05, 2026

Valion Bio receives protocol for radiation syndrome drug study - Investing.com

May 05, 2026
pulisher
May 05, 2026

Valion Bio receives first FDA-precedent study protocol from NIAID for Entolimod; federal agency to fully fund BLA-enabling in vivo program and co-navigate FDA submission - marketscreener.com

May 05, 2026
pulisher
May 05, 2026

Valion Bio receives protocol for radiation syndrome drug study By Investing.com - Investing.com Canada

May 05, 2026
pulisher
May 05, 2026

VALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSION - Morningstar

May 05, 2026
pulisher
May 04, 2026

Valion Bio Taps Legal-Science Hybrid to Drive Growth Strategy - BriefGlance

May 04, 2026
pulisher
May 04, 2026

Valion Bio (VBIO) grants 45,000 stock options to general counsel - Stock Titan

May 04, 2026
pulisher
May 04, 2026

Valion Bio (VBIO) General Counsel Melinda Lackey becomes reporting insider with Form 3 - Stock Titan

May 04, 2026
pulisher
May 04, 2026

Valion Bio (Nasdaq: VBIO) hires Melinda Lackey as General Counsel - Stock Titan

May 04, 2026
pulisher
May 01, 2026

VBIO Price Today: Valion Bio, Inc. Stock Price, Quote & Chart - MEXC

May 01, 2026
pulisher
Apr 30, 2026

VBIO | Valion Bio, Inc. Common Insider Trading - Quiver Quantitative

Apr 30, 2026
pulisher
Apr 30, 2026

VBIO | Valion Bio, Inc. Common Institutional Ownership - Quiver Quantitative

Apr 30, 2026
pulisher
Apr 30, 2026

VBIO | Valion Bio, Inc. Common Stock Data, Price & News - Quiver Quantitative

Apr 30, 2026
pulisher
Apr 30, 2026

[ARS] Tivic Health Systems, Inc. SEC Filing - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Valion Bio (TIVC) seeks approval for equity plan, financings and 2026 board vote - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

VBIO Price Today: Valion Bio, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 30, 2026
pulisher
Apr 30, 2026

Number of employees of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 30, 2026
pulisher
Apr 30, 2026

Valion Bio, Inc.: Shareholders Board Members Managers and Company Profile | US8887053085 - marketscreener.com

Apr 30, 2026
pulisher
Apr 30, 2026

Valion Bio, Inc.: Performance & Quotes, VBIO Stock Price on Nasdaq Exchange - marketscreener.com

Apr 30, 2026
pulisher
Apr 29, 2026

Free float of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 29, 2026
pulisher
Apr 28, 2026

Total liabilities of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Valion Bio, Inc. Balance Sheet – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

EBITDA margin % of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Return on equity % of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Valion Bio, Inc. Statistics – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

CapEx per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Inventory turnover of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Total equity of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Valion Bio, Inc. Dividends – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Valion Bio, Inc. Revenue Breakdown – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

EBITDA of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Valion Bio, Inc. Income Statement – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Operating income of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Valion Bio, Inc. Financial Statements – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

EBITDA per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Return on assets % of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Net income of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Basic earnings per share (basic EPS) of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Long term debt to total equity ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Enterprise value to EBITDA ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Current ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Debt to equity ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Working capital per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Book value per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Price to cash flow ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Net current asset value per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Quick ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Debt to assets ratio of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Operating margin % of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Gross margin % of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Total common shares outstanding of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Enterprise value of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Net margin % of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

EBIT per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Cash from investing activities of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Total debt of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Total debt per share of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Valion Bio, Inc. Cash Flow – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

EBIT of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Free cash flow of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Net debt of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Pretax income of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Non-operating income (total) of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Total revenue of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Valion Bio, Inc. Earnings and Revenue – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Operating expenses (excl. COGS) of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Diluted net income available to common stockholders of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Equity in earnings of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Taxes of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Diluted earnings per share (diluted EPS) of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Gross profit of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Non-controlling/minority interest of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Apr 28, 2026
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
Kapitalisierung:     |  Volumen (24h):